Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Adventrx halts Phase III colorectal cancer trial
The decision follows advice Adventrx received from the data safety monitoring board (DSMB), and comprehensive analysis of the recently completed Phase IIb clinical trial of CoFactor for the
The decision follows advice Adventrx received from the data safety monitoring board (DSMB), and comprehensive analysis of the recently completed Phase IIb clinical trial of CoFactor for the
At closing, Chelsea will issue approximately 7.4 million shares of its common stock at $6.62, which was the closing price on November 1, 2007. The financing is expected
The Food and Drug Administration (FDA) had previously reviewed Phase I through III clinical data involving gepirone extended release (ER). In June 2004, the FDA requested an additional
The investors have agreed to purchase the shares of common stock and warrants to purchase common stock at a negotiated purchase price of $2.845 per unit, each unit
The Repeat (REtreatment with PEgasys in pATients not responding to Peg-Intron therapy) study was designed to explore whether intensified treatment with a higher fixed-dose induction of Pegasys in
Patients in the study treated with a Simcor combination containing 20mg simvastatin had significantly better reductions in non-HDL (total cholesterol minus HDL) cholesterol compared to 20mg simvastatin therapy
Barr has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic Ritalin LA product with the Food & Drug Administration in May
The patent claims are based on a significant body of data supporting the use of thymosin beta 4 for wound healing of the cornea and other areas in
Daiichi Sankyo Company, and Eli Lilly and Company, which are co-developing prasugrel, will conduct the study in conjunction with the Duke Clinical Research Institute (DCRI). Lead study investigator
In order to prevent and control infectious diseases, improve public health and conform to national inoculation regulations, the Beijing Public Health Bureau has commenced the purchase of flu